Amarin Corporation announced results from the Phase 3 EPA for Metastasis Trial 2 (EMT2) showing that while VAZKEPA (icosapent ethyl) did not improve progression-free survival in colorectal cancer liver metastases patients undergoing liver resection, it significantly improved overall survival. Patients taking VAZKEPA had a 32% lower risk of death at 5 years compared to placebo, with a 62.0% survival rate versus 45.1%. The drug was well tolerated with no major safety concerns. These findings suggest VAZKEPA may offer a new adjunct therapy to extend survival in this high-risk cancer population, warranting further research.
Amarin's Phase 3 trial update on VAZKEPA shows a 32% lower risk of death at 5 years in colorectal cancer liver metastases patients. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 25, 2026 17:41 WIB: out of 150 priced US health stocks, 44 rose and 105 fell. Notable movers include ADPT at USD 25.51 (+4.51%), AMWL at USD 13.57 (-4.37%), and BNGO at USD 1.13 (-4.24%).
Chery unveiled its Globalisation 3.0 strategy at the 2026 International User Summit, aiming to transform from a traditional automaker into a high-tech integrated ecosystem by 2035. The strategy emphasizes AI adoption, green technologies, and local ma...
Unfair Links, founded by Rollo Unden and Oliver Fish, has launched a beta service providing local backlinks that are matched to a business's Google Business Profile, country, language, and page topic. Unlike generic backlinks, these links come from r...
Tango, a global live-streaming platform, has donated tens of thousands of dollars to support FRIDA Ukraine's mobile cancer screening program. This initiative brings essential cancer detection and preventive healthcare services directly to underserved...
California's upcoming AI safety mandate, effective May 15, 2027, is creating tension with federal military cybersecurity rules under the Defense Federal Acquisition Regulation Supplement (DFARS). Veteran-led engineering groups have developed advanced...
Greg Abel highlighted that every one-point increase in BNSF's profit margin translates to about $230 million in additional cash flow for Berkshire Hathaway. This underscores the significant impact BNSF's operational efficiency has on Berkshire's over...
